Top

Published in:

01-01-2017

Simultaneous large bi-atrial device-related thrombi

Authors: Jonas Dominik Häner, Christian Seiler

Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2017

Abstract

Simultaneous appearance of a pacemaker-lead associated thrombus and a left atrial appendage closure device related thrombus in a patient with urothelial carcinoma shown in a transesophageal echocardiography.

Available only for authorised users

Wun T, White RH (2009) Epidemiology of cancer-related venous thromboembolism. Best Pract Res Clinc Haematol 22:9–23. doi:10.1016/j.beha.2008.12.001 CrossRef

Carrier M, Cameron C, Delluc A, Castellucci L, Khorana AA, Lee AY (2014) Efficacy and safety of anticoagulant therapy for the treatment of acute cancer-associated thrombosis: a systematic review and meta-analysis. Thromb Res 134(6):1214–1219. doi:10.1016/j.thromres.2014.09.039 CrossRefPubMed

Mantha S, Laube E, Miao Y, Sarasohn DM, Parameswaran R, Stefanik S, Brar G, Samedy P, Wills J, Harnicar S, Soff GA (2016) Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study. J Thromb Thrombolysis (Epub ahead of print 2016 Sep 30). doi:10.1007/s11239-016-1429-1 PubMed

Becattini C, Agnelli G (2016) Treatment of venous thromboembolism with new anticoagulant agents. J Am Coll Cardiol 67(16):1941–1955. doi:10.1016/j.jacc.2016.01.072 CrossRefPubMed

Farge D, Bounameaux H, Brenner B, Cajfinger F, Debourdeau P, Khorana AA, Pabinger I, Solymoss S, Douketis J, Kakkar A (2016) International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol 17(10):e452–e466. doi:10.1016/S1470-2045(16)30369-2 CrossRefPubMed

Khorana AA, Carrier M, Garcia DA, Lee AY (2016) Guidance for the prevention and treatment of cancer-associated venous thromboembolism. J Thromb Thrombolysis 41(1):81–91. doi:10.1007/s11239-015-1313-4 CrossRefPubMedPubMedCentral

Title: Simultaneous large bi-atrial device-related thrombi
Authors: Jonas Dominik Häner
Christian Seiler
Publication date: 01-01-2017
Publisher: Springer US
Published in: Journal of Thrombosis and Thrombolysis / Issue 1/2017
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-016-1453-1

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Simultaneous large bi-atrial device-related thrombi

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2017

Thrombocytopenia in hospitalized patients with severe clostridium difficile infection

The use of direct oral anticoagulants in inherited thrombophilia

Assessing in vivo platelet activation in patients with liver diseases

Thromboembolic complications following a first isolated episode of superficial vein thrombosis: a cross-sectional retrospective study

Adjustment of therapeutic LMWH to achieve specific target anti-FXa activity does not affect outcomes in pregnant patients with venous thromboembolism

Additive prognostic value of left ventricular ejection fraction to the TIMI risk score for in-hospital and long-term mortality in patients with ST segment elevation myocardial infarction

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page